Insights On Regulatory Compliance
-
The Impact Of Instrument Characteristics On The Method Migration Of A Challenging USP Assay
9/3/2024
To evaluate the impact of different systems on the USP monograph for azithromycin organic impurities, the organic impurities monograph was tested across multiple chromatographic systems.
-
Water For Injection: Strategic Utility And The Case For Outsourcing
3/9/2026
Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.
-
The Invaluable Asset Driving Advanced Therapies Forward
6/19/2026
Cell therapies are advancing rapidly, but manufacturing delays still limit patient access. Improving operational understanding, reducing risk, and strengthening collaboration may be just as critical.
-
Don't Lose Sight Of Ophthalmic Injectables' Regulatory Complexity
8/17/2026
Intravitreal injectables face some of the strictest regulatory scrutiny in drug development. Learn what sponsors need to know about EU GMP Annex 1, USP standards, and container closure integrity to stay compliant.
-
How To Handle Intrinsic Product Powder Particles
3/16/2026
Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements.
-
Redefining Process Design And The Evolution Of Critical Process Parameters
8/6/2025
Effectively managing process parameters and quality attributes is vital for successful drug development. Learn how a Quality by Design approach can optimize your processes and ensure product quality.
-
Why Biopharma Breakthroughs Aren't Moving The Market
10/20/2025
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
Liberating Intelligence: The Industrial AI Orchestration Layer
1/15/2026
Unlock predictive manufacturing by bridging IT and OT. The Industrial AI Orchestration Layer delivers real-time insights, compliance, and scalability, turning fragmented data into actionable intelligence.
-
Leachables Method Development, Validation And Relevant ICH References
5/16/2025
It is crucial to develop and validate analytical methods capable of detecting a wide range of potential organic and inorganic leachables specific to the drug and its packaging.
-
Understanding Biotherapeutic Peptides And GLP-1 Receptor Agonists
9/2/2025
Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.